Ambrosy Andrew P, Hernandez Adrian F, Armstrong Paul W, Butler Javed, Dunning Allison, Ezekowitz Justin A, Felker G Michael, Greene Stephen J, Kaul Padma, McMurray John J, Metra Marco, O'Connor Christopher M, Reed Shelby D, Schulte Phillip J, Starling Randall C, Tang W H Wilson, Voors Adriaan A, Mentz Robert J
Duke University Medical Center, Durham, NC, USA.
Duke Clinical Research Institute, Durham, NC, USA.
Eur J Heart Fail. 2016 Mar;18(3):306-13. doi: 10.1002/ejhf.420. Epub 2015 Oct 14.
A longitudinal and comprehensive analysis of health-related quality of life (HRQOL) was performed during hospitalization for heart failure (HF) or soon after discharge.
A post-hoc analysis was performed of the ASCEND-HF trial. The EuroQOL five dimensions questionnaire (EQ-5D) was administered to study participants at baseline, 24 h, discharge/day 10, and day 30. EQ-5D includes functional dimensions mapped to corresponding utility scores (i.e. 0 = death and 1 = perfect health), and a visual analogue scale (VAS) ranging from 0 (i.e. 'worst imaginable health state') to 100 (i.e. 'best imaginable health state'). The association between baseline and discharge EQ-5D measurements and subsequent clinical outcomes including death and rehospitalization were assessed using multivariable logistic regression and Cox proportional hazards regression. A total of 6943 patients (97%) had complete EQ-5D data at baseline. Mapped utility and VAS scores (mean ± SD) increased over time, respectively, from 0.56 ± 0.23 and 45 ± 22 at baseline to 0.67 ± 0.26 and 58 ± 22 at 24 h and to 0.79 ± 0.20 and 68 ± 22 at discharge, and remained stable at day 30. Lower mapped utility scores at baseline [odds ratio (OR) per 0.1 decrease in utility score 1.03, 95% confidence interval (CI) 1.00-1.06] and discharge (OR 1.10, 95% CI 1.05-1.15) and VAS scores at baseline (OR per 10 point decrease 1.05, 95% CI 1.01-1.09) were significantly associated with increased risk of 30-day all-cause death or HF rehospitalization.
Patients hospitalized for HF had severely impaired health status at baseline and, although this improved substantially during admission, health status remained abnormal at discharge.
在心力衰竭(HF)住院期间或出院后不久,对健康相关生活质量(HRQOL)进行纵向和全面分析。
对ASCEND-HF试验进行事后分析。在基线、24小时、出院/第10天和第30天,对研究参与者进行欧洲五维健康量表(EQ-5D)评估。EQ-5D包括映射到相应效用分数的功能维度(即0 = 死亡,1 = 完美健康),以及一个从0(即“可想象到的最差健康状态”)到100(即“可想象到的最佳健康状态”)的视觉模拟量表(VAS)。使用多变量逻辑回归和Cox比例风险回归评估基线和出院时EQ-5D测量值与随后包括死亡和再住院在内的临床结局之间的关联。共有6943名患者(97%)在基线时有完整的EQ-5D数据。映射的效用和VAS分数(均值±标准差)随时间增加,分别从基线时的0.56±0.23和45±22增加到24小时时的0.67±0.26和58±22,出院时为0.79±0.20和68±22,并在第30天保持稳定。基线时较低的映射效用分数[效用分数每降低0.1的比值比(OR)为1.03,95%置信区间(CI)为1.00 - 1.06]和出院时(OR为1.10,95% CI为1.05 - 1.15)以及基线时的VAS分数(每降低10分的OR为1.05,95% CI为1.01 - 1.09)与30天全因死亡或HF再住院风险增加显著相关。
因HF住院的患者在基线时健康状况严重受损,尽管在住院期间有显著改善,但出院时健康状况仍不正常。